Derbend Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Derbend Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$250K	Sell
2023 Q4	$235K	Buy
2023 Q3	–	Sell
2023 Q2	$234K	Buy
2022 Q4	–	Sell
2022 Q3	$300K	Sell
2022 Q2	$284K	Sell
2022 Q1	$888K	Hold
2021 Q4	$888K	Sell
2021 Q3	$1.56M	Buy
2021 Q2	$2.02M	Buy